Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction.
Alisky
Joseph Martin
JM
D001344:Autopsy; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003072:Cognition Disorders / Q000139:chemically induced* / Q000517:prevention & control; D003702:Delusions / Q000139:chemically induced* / Q000517:prevention & control; D004298:Dopamine / Q000032:analysis; D006212:Hallucinations / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000188:drug therapy*
D000697:Central Nervous System Stimulants; D002800:Cholinesterase Inhibitors; D008694:Methamphetamine; D004298:Dopamine